About this Journal Submit a Manuscript Table of Contents
Volume 2013 (2013), Article ID 891403, 18 pages
Review Article

HDL, Atherosclerosis, and Emerging Therapies

1McGill University, Montreal, QC, Canada H3A 1A1
2Faculty of Medicine, Center for Innovative Medicine, McGill University Health Center, Royal Victoria Hospital, McGill University, 687 Pine Avenue West, Montreal, QC, Canada H3A 1A1

Received 27 February 2013; Revised 22 April 2013; Accepted 30 April 2013

Academic Editor: Francisco Blanco-Vaca

Copyright © 2013 Anouar Hafiane and Jacques Genest. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [7 citations]

The following is the list of published articles that have cited the current article.

  • G. Klose, and R. Hambrecht, “HDL – „Game over“?,” Der Kardiologe, vol. 7, no. 5, pp. 346–351, 2013. View at Publisher · View at Google Scholar
  • Ki-Chul Sung, Sarah H. Wild, and Christopher D. Byrne, “Controlling for apolipoprotein A-I concentrations changes the inverse direction of the relationship between high HDL-C concentration and a measure of pre-clinical atherosclerosis,” Atherosclerosis, vol. 231, no. 2, pp. 181–186, 2013. View at Publisher · View at Google Scholar
  • Anouar Hafiane, Bashar Jabor, Isabelle Ruel, Jennifer Ling, and Jacques Genest, “High-Density Lipoprotein Mediated Cellular Cholesterol Efflux in Acute Coronary Syndromes,” The American Journal of Cardiology, 2013. View at Publisher · View at Google Scholar
  • Bronwyn A. Kingwell, M. John Chapman, Anatol Kontush, and Norman E. Miller, “HDL-targeted therapies: progress, failures and future,” Nature Reviews Drug Discovery, 2014. View at Publisher · View at Google Scholar
  • Anouar Hafiane, Samantha Kellett, and Jacques Genest, “Treatment options for low high-density lipoproteins,” Current Opinion in Endocrinology & Diabetes and Obesity, vol. 21, no. 2, pp. 134–139, 2014. View at Publisher · View at Google Scholar
  • R. J. Doonan, A. Hafiane, C. Lai, J. P. Veinot, J. Genest, and S. S. Daskalopoulou, “Cholesterol Efflux Capacity, Carotid Atherosclerosis, and Cerebrovascular Symptomatology,” Arteriosclerosis Thrombosis and Vascular Biology, vol. 34, no. 4, pp. 921–926, 2014. View at Publisher · View at Google Scholar
  • Jean Davignon, Michel P. Hermans, Khalid Al-Rubeaan, Pierre Amarenco, Gerd Assmann, Philip Barter, John Betteridge, Eric Bruckert, Ada Cuevas, Michel Farnier, Ele Ferrannini, Paola Fioretto, Jacques Genest, Henry N. Ginsberg, Antonio M. Gotto, Dayi Hu, Takashi Kadowaki, Tatsuhiko Kodama, Michel Krempf, Yuji Matsuzawa, Jesus Millan Nunez-Cortes, Carlos Calvo Monfil, Hisao Ogawa, Jorge Plutzky, Daniel J. Rader, Shaukat Sadikot, Raul D. Santos, Evgeny Shlyakhto, Piyamitr Sritara, Rody Sy, Alan Tall, Chee Eng Tan, Lale Tokgozoglu, Peter P. Toth, Paul Valensi, Christoph Wanner, Alberto Zambon, Junren Zhu, and Paul Zimmet, “Residual macrovascular risk in 2013: what have we learned?,” Cardiovascular Diabetology, vol. 13, 2014. View at Publisher · View at Google Scholar